Correlation Between Biotron and Veritas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotron and Veritas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotron and Veritas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotron Limited and Veritas Pharma, you can compare the effects of market volatilities on Biotron and Veritas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotron with a short position of Veritas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotron and Veritas Pharma.

Diversification Opportunities for Biotron and Veritas Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Biotron and Veritas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Biotron Limited and Veritas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veritas Pharma and Biotron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotron Limited are associated (or correlated) with Veritas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veritas Pharma has no effect on the direction of Biotron i.e., Biotron and Veritas Pharma go up and down completely randomly.

Pair Corralation between Biotron and Veritas Pharma

If you would invest  1.30  in Biotron Limited on September 2, 2025 and sell it today you would lose (1.18) from holding Biotron Limited or give up 90.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.56%
ValuesDaily Returns

Biotron Limited  vs.  Veritas Pharma

 Performance 
       Timeline  
Biotron Limited 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotron Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Biotron reported solid returns over the last few months and may actually be approaching a breakup point.
Veritas Pharma 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Veritas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Veritas Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Biotron and Veritas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotron and Veritas Pharma

The main advantage of trading using opposite Biotron and Veritas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotron position performs unexpectedly, Veritas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veritas Pharma will offset losses from the drop in Veritas Pharma's long position.
The idea behind Biotron Limited and Veritas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes